---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-279656"
form_type: "8-K"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T02:48:50.443185+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Jazz CEO Bruce Cozadd to retire by end of 2025; company to search for successor

## Summary
- Bruce Cozadd notified Board of intent to retire as CEO upon appointment of successor.
- Formal search process will consider both internal and external candidates for CEO.
- After retiring as CEO, Cozadd will continue to serve as Chairperson of the Board.
- Cozadd remains CEO until successor is appointed; transition expected by end of 2025.

## SEC filing metadata
- accession: 0001193125-24-279656
- form_type: 8-K
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000119312524279656/0001193125-24-279656-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000119312524279656/d907309d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-279656
- JSON: https://secwatch.observer/filing/0001193125-24-279656.json
- Plain text: https://secwatch.observer/filing/0001193125-24-279656.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.